Gusev 1997 — Semax in Acute Ischemic Stroke

Zh Nevrol Psikhiatr Im S S Korsakova

Gusev EI, et al.

Summary

Foundational stroke trial for Russian Semax registration

Study Details

Study Design

Non-randomized clinical trial with concurrent control

Indication

Acute hemispheric ischemic stroke

Intervention

12-18 mg/day intranasal

Species

Human

Sample Size

30 subjects

Risk of Bias Assessment

Russian trial; non-randomized